Sopharma issued the following announcement.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for March 2019 the Company recorded an increase of sales revenues of 16% compared to the same month of 2018, including 11% increase of domestic sales and an increase of 22% of export sales.
In the first quarter of 2019 the revenues from sales of production decreased by 2% compared to the first quarter of 2018, including 18% decrease in domestic sales and 11% increase of export sales.
Original source can be found here.
